ADV PHARM FINAL
EXAM WITH Q&A NEWLY MODIFIED TESTED AND
APPROVED 2025/2026 LATEST!!!
Postmenopausal women with an intact uterus should not be prescribed:
1. Estrogen/progesterone combination
2. IM medroxyprogesterone (Depo Provera)
3. Estrogen alone
4. Androgens -- ANSWER--Estrogen alone
William is a 62-year old male is requesting a prescription for sildenafil (Viagra). Before
receiving his prescription, William should be screened for:
1. Renal dysfunction
2. Unstable coronary artery disease
3. Benign prostatic hypertrophy
4. History of priapism -- ANSWER--Unstable coronary artery disease
A 56-year old woman is complaining of vaginal dryness and dyspareunia. To treat her
symptoms with the lowest adverse effects she should be prescribed:
1. Low-dose oral estrogen
2. A low-dose estrogen/progesterone combination
3. A vaginal estradiol ring
4. Vaginal progesterone cream -- ANSWER--A vaginal estradiol ring
Page 1 of 126
,Shana received her first medroxyprogesterone (Depo-provera) injection six weeks ago and
calls the clinic, concerned that she has been having a light period off and on since receiving
her Depo shot. What should the provider do?
1. Reassurance that some spotting is normal the first few months of Depo and it should
improve.
2. Schedule an appointment for an exam as this is not normal.
3. Prescribe 4 weeks of estrogen to treat the abnormal vaginal bleeding.
4. Order a pregnancy test and suggest she use a back-up method of contraception until
she has her next shot. -- ANSWER--Reassurance that some spotting is normal the first few
months of Depo and it should improve.
Education when prescribing androgens to male patients includes advising that:
1. Short-term use places the patient at risk for hepatocellular carcinoma.
2. Cholestatic hepatitis and jaundice may occur with low doses of androgens.
3. Gynecomastia is a rare occurrence with the use of androgens.
4. Low sperm levels only occur with long-term use of androgens. -- ANSWER--
Cholestatic hepatitis and jaundice may occur with low doses of androgens.
A 22-year-old woman receives a prescription for oral contraceptives. Education for this
patient includes:
1. Counselling regarding decreasing or not smoking while taking oral contraceptives
2. Advising a monthly pregnancy test for the first 3 months she is taking the
contraceptive
3. Advising that she may miss two pills in a row and not be concerned about pregnancy
4. Recommending that her next follow-up visit is in 1 year for a refill and annual exam -
-
ANSWER--Counseling regarding decreasing or not smoking while taking oral contraceptives
Page 2 of 126
,Androgens are indicated for :
1. Symptomatic treatment in both sexes for cancer and HIV
2. Female libido, endometriosis, and postmenopausal symptoms
3. Increased muscle mass in frail women
4. Symptomatic treatment in male deficiency -- ANSWER--Symptomatic treatment in
male deficiency
Men who are prescribed sildenafil (Viagra) need ongoing monitoring for:
1. Development of chest pain or dizziness
2. Weight gain
3. Priapism
4. Renal function -- ANSWER--Development of chest pain or dizziness
The medroxyprogesterone (Depo-Provera) injection has a black box warning due to
1. The potential development of significant hypertension
2. Increased risk of strokes
3. Decreased bone density
4. The risk of a life-threatening rash such as Stevens-Johnson -- ANSWER--Decreased
bone density
When prescribing medroxyprogesterone (Depo-Provera) injections, essential education would
include advising of the following potential adverse drug effects:
a. abdominal pain and Constipation
b. hypertension and dysuria
Page 3 of 126
, c. Orthostatic hypotension and dermatitis
d. depression and weight gain -- ANSWER--depression and weight gain
Men who are prescribed an erectile dysfunction drug such as sildenafil (Viagra) should be
warned about the risk for:
1. Impotence when combined with antihypertensives
2. Fatal hypotension if combined with nitrates
3. Weight gain if combined with antidepressants
4. All of the above -- ANSWER--Fatal hypotension if combined with nitrates
Absolute contraindications to estrogen therapy include:
1. History of any type of cancer
2. Clotting disorders
3. History of tension headaches
4. Orthostatic hypotension -- ANSWER--Clotting disorders
Shana is receiving her first medroxyprogesterone (Depo-Provera) injection. Shana will need
to be monitored for: 1. Depression
2. Hypertension
3. Weight loss
4. Cataracts -- ANSWER--Depression
The positive risk-benefit profile for all HRT indications may accrue when therapy is started:
a. near the time of menopause onset
b. after menopause has concluded
Page 4 of 126
EXAM WITH Q&A NEWLY MODIFIED TESTED AND
APPROVED 2025/2026 LATEST!!!
Postmenopausal women with an intact uterus should not be prescribed:
1. Estrogen/progesterone combination
2. IM medroxyprogesterone (Depo Provera)
3. Estrogen alone
4. Androgens -- ANSWER--Estrogen alone
William is a 62-year old male is requesting a prescription for sildenafil (Viagra). Before
receiving his prescription, William should be screened for:
1. Renal dysfunction
2. Unstable coronary artery disease
3. Benign prostatic hypertrophy
4. History of priapism -- ANSWER--Unstable coronary artery disease
A 56-year old woman is complaining of vaginal dryness and dyspareunia. To treat her
symptoms with the lowest adverse effects she should be prescribed:
1. Low-dose oral estrogen
2. A low-dose estrogen/progesterone combination
3. A vaginal estradiol ring
4. Vaginal progesterone cream -- ANSWER--A vaginal estradiol ring
Page 1 of 126
,Shana received her first medroxyprogesterone (Depo-provera) injection six weeks ago and
calls the clinic, concerned that she has been having a light period off and on since receiving
her Depo shot. What should the provider do?
1. Reassurance that some spotting is normal the first few months of Depo and it should
improve.
2. Schedule an appointment for an exam as this is not normal.
3. Prescribe 4 weeks of estrogen to treat the abnormal vaginal bleeding.
4. Order a pregnancy test and suggest she use a back-up method of contraception until
she has her next shot. -- ANSWER--Reassurance that some spotting is normal the first few
months of Depo and it should improve.
Education when prescribing androgens to male patients includes advising that:
1. Short-term use places the patient at risk for hepatocellular carcinoma.
2. Cholestatic hepatitis and jaundice may occur with low doses of androgens.
3. Gynecomastia is a rare occurrence with the use of androgens.
4. Low sperm levels only occur with long-term use of androgens. -- ANSWER--
Cholestatic hepatitis and jaundice may occur with low doses of androgens.
A 22-year-old woman receives a prescription for oral contraceptives. Education for this
patient includes:
1. Counselling regarding decreasing or not smoking while taking oral contraceptives
2. Advising a monthly pregnancy test for the first 3 months she is taking the
contraceptive
3. Advising that she may miss two pills in a row and not be concerned about pregnancy
4. Recommending that her next follow-up visit is in 1 year for a refill and annual exam -
-
ANSWER--Counseling regarding decreasing or not smoking while taking oral contraceptives
Page 2 of 126
,Androgens are indicated for :
1. Symptomatic treatment in both sexes for cancer and HIV
2. Female libido, endometriosis, and postmenopausal symptoms
3. Increased muscle mass in frail women
4. Symptomatic treatment in male deficiency -- ANSWER--Symptomatic treatment in
male deficiency
Men who are prescribed sildenafil (Viagra) need ongoing monitoring for:
1. Development of chest pain or dizziness
2. Weight gain
3. Priapism
4. Renal function -- ANSWER--Development of chest pain or dizziness
The medroxyprogesterone (Depo-Provera) injection has a black box warning due to
1. The potential development of significant hypertension
2. Increased risk of strokes
3. Decreased bone density
4. The risk of a life-threatening rash such as Stevens-Johnson -- ANSWER--Decreased
bone density
When prescribing medroxyprogesterone (Depo-Provera) injections, essential education would
include advising of the following potential adverse drug effects:
a. abdominal pain and Constipation
b. hypertension and dysuria
Page 3 of 126
, c. Orthostatic hypotension and dermatitis
d. depression and weight gain -- ANSWER--depression and weight gain
Men who are prescribed an erectile dysfunction drug such as sildenafil (Viagra) should be
warned about the risk for:
1. Impotence when combined with antihypertensives
2. Fatal hypotension if combined with nitrates
3. Weight gain if combined with antidepressants
4. All of the above -- ANSWER--Fatal hypotension if combined with nitrates
Absolute contraindications to estrogen therapy include:
1. History of any type of cancer
2. Clotting disorders
3. History of tension headaches
4. Orthostatic hypotension -- ANSWER--Clotting disorders
Shana is receiving her first medroxyprogesterone (Depo-Provera) injection. Shana will need
to be monitored for: 1. Depression
2. Hypertension
3. Weight loss
4. Cataracts -- ANSWER--Depression
The positive risk-benefit profile for all HRT indications may accrue when therapy is started:
a. near the time of menopause onset
b. after menopause has concluded
Page 4 of 126
